-
Combined oral contraceptives (OCs) help decrease a womans risk for epithelial ovarian cancer and endometrial cancer, reduce her risk of pelvic inflammatory disease and ectopic pregnancy, and lessen menstrual cramps and pain. But what is their impact on bone mineral density (BMD)?
-
Whats the impact of concomitant medications on combined oral contraceptives (OCs)?
-
Enter abstracts for ARHP annual conference; New payment options announced for Mirena
-
Family planning clinicians have found their care of postmenopausal women has changed dramatically since the July 2002 cessation of the estrogen/progestin arm of the Womens Health Initiative (WHI). The estrogen/progestin arm of the landmark study was halted after findings showed that the overall health risk, particularly of cardiovascular disease and breast cancer, from taking estrogens with progestin was greater than the benefits of lowering the risk of colon cancer and bone fractures.
-
Check out the following Internet resources for more information on hormone therapy.
-
If the number of men on your patient rosters is low, take a look at the approach used by Planned Parenthood of San Antonio and South Central Texas. In the first year of its marketing initiative, the number of its male patients nearly doubled from 2% to 3.7% of total patients served.
-
-
This article reviews multiple aspects of heart failure, providing direction for workup and management of heart failure patients. All recommendations follow current published guidelines. Unresolved and controversial issues are reviewed, and future therapies are proposed.
-
FDA Issues Black Box Warning Based on WHI Study; ALLHAT: Thiazide for Hypertension Treatment; Candesartan Effective Against Migraines; Cough! No Cold Relief from Echinacea; COX-2 Inhibitors and GI Benefits Could Be Overrated; FDA Actions;
-
